These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 33762177

  • 1. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.
    Chen YQ, Pottanat TG, Zhen EY, Siegel RW, Ehsani M, Qian YW, Konrad RJ.
    J Lipid Res; 2021; 62():100068. PubMed ID: 33762177
    [Abstract] [Full Text] [Related]

  • 2. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
    Balasubramaniam D, Schroeder O, Russell AM, Fitchett JR, Austin AK, Beyer TP, Chen YQ, Day JW, Ehsani M, Heng AR, Zhen EY, Davies J, Glaesner W, Jones BE, Siegel RW, Qian YW, Konrad RJ.
    J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
    [Abstract] [Full Text] [Related]

  • 3. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
    Wen Y, Chen YQ, Konrad RJ.
    Curr Opin Lipidol; 2024 Apr 01; 35(2):58-65. PubMed ID: 37962908
    [Abstract] [Full Text] [Related]

  • 4. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
    Chen YQ, Yang Y, Zhen EY, Beyer TP, Li H, Wen Y, Ehsani M, Jackson N, Xie K, Jung H, Scheithauer JL, Kumari A, Birrane G, Russell AM, Balasubramaniam D, Liao Z, Siegel RW, Qian Y, Ploug M, Young SG, Konrad RJ.
    Proc Natl Acad Sci U S A; 2024 Apr 23; 121(17):e2322332121. PubMed ID: 38625948
    [Abstract] [Full Text] [Related]

  • 5. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
    Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, Li W, Dou A, Zhang R, Davies BSJ.
    Mol Metab; 2017 Oct 23; 6(10):1137-1149. PubMed ID: 29031715
    [Abstract] [Full Text] [Related]

  • 6. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
    Landfors F, Chorell E, Kersten S.
    J Lipid Res; 2023 Jan 23; 64(1):100313. PubMed ID: 36372100
    [Abstract] [Full Text] [Related]

  • 7. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
    Haller JF, Mintah IJ, Shihanian LM, Stevis P, Buckler D, Alexa-Braun CA, Kleiner S, Banfi S, Cohen JC, Hobbs HH, Yancopoulos GD, Murphy AJ, Gusarova V, Gromada J.
    J Lipid Res; 2017 Jun 23; 58(6):1166-1173. PubMed ID: 28413163
    [Abstract] [Full Text] [Related]

  • 8. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
    DiDonna NM, Chen YQ, Konrad RJ.
    Curr Opin Lipidol; 2022 Feb 01; 33(1):39-46. PubMed ID: 34789669
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
    Lee EC, Desai U, Gololobov G, Hong S, Feng X, Yu XC, Gay J, Wilganowski N, Gao C, Du LL, Chen J, Hu Y, Zhao S, Kirkpatrick L, Schneider M, Zambrowicz BP, Landes G, Powell DR, Sonnenburg WK.
    J Biol Chem; 2009 May 15; 284(20):13735-13745. PubMed ID: 19318355
    [Abstract] [Full Text] [Related]

  • 13. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.
    Sylvers-Davie KL, Davies BSJ.
    Am J Physiol Endocrinol Metab; 2021 Oct 01; 321(4):E493-E508. PubMed ID: 34338039
    [Abstract] [Full Text] [Related]

  • 14. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
    Chen YQ, Pottanat TG, Siegel RW, Ehsani M, Qian YW, Roell WC, Konrad RJ.
    Biochem Biophys Res Commun; 2021 Jan 01; 534():498-503. PubMed ID: 33239171
    [Abstract] [Full Text] [Related]

  • 15. Postprandial exercise regulates tissue-specific triglyceride uptake through angiopoietin-like proteins.
    Liu X, Zhang Y, Han B, Li L, Li Y, Ma Y, Kang S, Li Q, Kong L, Huang K, Song BL, Liu Y, Wang Y.
    JCI Insight; 2024 Aug 22; 9(16):. PubMed ID: 39171527
    [Abstract] [Full Text] [Related]

  • 16. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
    Sylvers-Davie KL, Segura-Roman A, Salvi AM, Schache KJ, Davies BSJ.
    J Lipid Res; 2021 Aug 22; 62():100112. PubMed ID: 34461133
    [Abstract] [Full Text] [Related]

  • 17. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
    Kovrov O, Kristensen KK, Larsson E, Ploug M, Olivecrona G.
    J Lipid Res; 2019 Apr 22; 60(4):783-793. PubMed ID: 30686789
    [Abstract] [Full Text] [Related]

  • 18. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
    Zhang R, Zhang K.
    Prog Lipid Res; 2022 Jan 22; 85():101140. PubMed ID: 34793860
    [Abstract] [Full Text] [Related]

  • 19. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
    Murawska K, Krintus M, Kuligowska-Prusinska M, Szternel L, Stefanska A, Sypniewska G.
    Nutrients; 2021 Nov 30; 13(12):. PubMed ID: 34959891
    [Abstract] [Full Text] [Related]

  • 20. ANGPTL4: a new mode in the regulation of intravascular lipolysis.
    Ploug M.
    Curr Opin Lipidol; 2022 Apr 01; 33(2):112-119. PubMed ID: 34860701
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.